Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Editorial

Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head?

In Press, (this is not the final "Version of Record"). Available online 03 April, 2024
Author(s): Ilias Giannakodimos*
Published on: 03 April, 2024

DOI: 10.2174/0109298673304111240325062717

Price: $95

[1]
Payne, H.; Cornford, P. Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer. Urol. Oncol., 2011, 29(6), 593-601.
[http://dx.doi.org/10.1016/j.urolonc.2009.11.003] [PMID: 20060331]
[2]
Roehrborn, C.G. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia. Int. J. Impot. Res., 2008, 20(S3)(Suppl. 3), S19-S26.
[http://dx.doi.org/10.1038/ijir.2008.53] [PMID: 19002120]
[3]
O’Shea, A.; Harisinghani, M. PI-RADS: Multiparametric MRI in prostate cancer. Magn. Reson. Mater. Biol. Phys. Med., 2022, 35(4), 523-532.
[http://dx.doi.org/10.1007/s10334-022-01019-1] [PMID: 35596009]
[4]
Yoneyama, T.; Tobisawa, Y.; Kaneko, T.; Kaya, T.; Hatakeyama, S.; Mori, K.; Sutoh Yoneyama, M.; Okubo, T.; Mitsuzuka, K.; Duivenvoorden, W.; Pinthus, J.H.; Hashimoto, Y.; Ito, A.; Koie, T.; Suda, Y.; Gardiner, R.A.; Ohyama, C. Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection. Cancer Sci., 2019, 110(8), 2573-2589.
[http://dx.doi.org/10.1111/cas.14082] [PMID: 31145522]
[5]
Ziogou, A.; Giannakodimos, A.; Giannakodimos, I. The role of urinary miRNAs in the diagnosis, management and follow-up of prostatic cancer. MicroRNA, 2023, 12(2), 83-86.
[http://dx.doi.org/10.2174/2211536612666230324102850] [PMID: 36999432]
[6]
Giannakodimos, I. Urinary miRNAs as diagnostic biomarkers for prostatic cancer: Current dilemmas and novel potential role for a digital rectal examination. Curr. Med. Chem., 2022, 29(25), 4311-4313.
[http://dx.doi.org/10.2174/0929867329666220118101733] [PMID: 35040397]
[7]
Paiva, R.M.; Zauli, D.A.G.; Neto, B.S.; Brum, I.S. Urinary microRNAs expression in prostate cancer diagnosis: A systematic review. Clin. Transl. Oncol., 2020, 22(11), 2061-2073.
[http://dx.doi.org/10.1007/s12094-020-02349-z] [PMID: 32323148]
[8]
Casanova-Salas, I.; Rubio-Briones, J.; Calatrava, A.; Mancarella, C.; Masiá, E.; Casanova, J.; Fernández-Serra, A.; Rubio, L.; Ramírez-Backhaus, M.; Armiñán, A.; Domínguez-Escrig, J.; Martínez, F.; García-Casado, Z.; Scotlandi, K.; Vicent, M.J.; López-Guerrero, J.A. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J. Urol., 2014, 192(1), 252-259.
[http://dx.doi.org/10.1016/j.juro.2014.01.107] [PMID: 24518785]
[9]
Aveta, A.; Cilio, S.; Contieri, R.; Spena, G.; Napolitano, L.; Manfredi, C.; Franco, A.; Crocerossa, F.; Cerrato, C.; Ferro, M.; Del Giudice, F.; Verze, P.; Lasorsa, F.; Salonia, A.; Nair, R.; Walz, J.; Lucarelli, G.; Pandolfo, S.D. Urinary MicroRNAs as biomarkers of urological cancers: A systematic review. Int. J. Mol. Sci., 2023, 24(13), 10846.
[http://dx.doi.org/10.3390/ijms241310846] [PMID: 37446024]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy